Apolipoprotein B is related to arterial pulse wave velocity in young adults: The Cardiovascular Risk in Young Finns Study

Atherosclerosis

Volumn 214, Issue 1, 2011, Pages 220-224

  Koivistoinen, Teemu ^a   Hutri Kähönen, Nina ^a   Juonala, Markus ^b,c   Kööbi, Tiit ^a   Aatola, Heikki ^a   Lehtimäki, Terho ^a   Viikari, Jorma S A ^b   Raitakari, Olli T ^b,c   Kähönen, Mika ^a,d  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Arterial stiffness; Cardiovascular health; Epidemiology; Pulse wave velocity; Young adults

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; FEMALE; HEART RATE; HUMAN; IMPEDANCE CARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; SYSTOLIC BLOOD PRESSURE;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ARTERIES; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; RANDOM ALLOCATION; RISK FACTORS; YOUNG ADULT;

EID: 78650812020     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.10.037     Document Type: Article

References (33)

1. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
2. Walldius G., Jungner I., Holme I., Aastveit A.H., Kolar W., Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001, 358:2026-2033.
3. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
4. Lamarche B., Moorjani S., Lupien P.J., et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study. Circulation 1996, 94:273-278.
5. Sniderman A.D., Furberg C.D., Keech A., et al. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003, 361:777-780.
6. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010, 55:1318-1327.
7. Aatola H., Hutri-Kähönen N., Juonala M., et al. Lifetime risk factors and arterial pulse wave velocity in adulthood, The Cardiovascular Risk in Young Finns Study. Hypertension 2010, 55:806-811.
8. Benetos A., Waeber B., Izzo J., et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 2002, 15:1101-1108.
9. Cecelja M., Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 2009, 54:1328-1336.
10. Li S., Chen W., Srinivasan S.R., Berenson G.S. Childhood blood pressure as a predictor of arterial stiffness in young adults: the Bogalusa heart study. Hypertension 2004, 43:541-546.
11. Amar J., Ruidavets J.B., Chamontin B., Drouet L., Ferrières J. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 2001, 19:381-387.
12. Schmidt-Trucksäss A.S., Grathwohl D., Frey I., et al. Relation of leisure-time physical activity to structural and functional arterial properties of the common carotid artery in male subjects. Atherosclerosis 1999, 145:107-114.
13. Åkerblom H.K., Viikari J., Uhari M., et al. Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross-sectional study of 1980, and an account of the children's and families' state of health. Acta Paediatr Scand, Suppl 1985, 318:49-63.
14. Juonala M., Viikari J.S., Kähönen M., et al. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study. J Am Coll Cardiol 2008, 52:293-299.
15. Juonala M., Järvisalo M.J., Mäki-Torkko N., Kähönen M., Viikari J.S., Raitakari O.T. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study. Circulation 2005, 112:1486-1493.
16. Juonala M., Viikari J.S., Hutri-Kähönen N., et al. The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference. J Intern Med 2004, 255:457-468.
17. Juonala M., Viikari J.S., Rönnemaa T., Taittonen L., Marniemi J., Raitakari O.T. Childhood C-reactive protein in predicting CRP and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 2006, 26:1883-1888.
18. Raiko J.R., Viikari J.S., Ilmanen A., et al. Follow-ups of the cardiovascular risk in Young Finns Study in 2001 and 2007: levels and 6-year changes in risk factors. J Intern Med 2010, 267:370-384.
19. Kööbi T., Kähönen M., Iivainen T., Turjanmaa V. Simultaneous non-invasive assessment of arterial stiffness and haemodynamics-a validation study. Clin Physiol Funct Imaging 2003, 23:31-36.
20. Lantelme P., Mestre C., Lievre M., Gressard A., Milon H. Heart rate: an important confounder of pulse wave velocity assessment. Hypertension 2002, 39:1083-1087.
21. Mitchell G.F., Parise H., Benjamin E.J., et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 2004, 43:1239-1245.
22. Le N.A., Brown W.V., Davis W.W., et al. Comparison of the relation of triglyceride-rich lipoproteins and muscular artery compliance in healthy women versus healthy men. Am J Cardiol 2005, 95:1049-1054.
23. Taquet A., Bonithon-Kopp C., Simon A., et al. Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol 1993, 9:298-306.
24. Marcovina S., Packard C.J. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Intern Med 2006, 259:437-446.
25. Sniderman A.D., Scantlebury T., Cianflone K. Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 2001, 135:447-459.
26. Rasouli M., Kiasari A.M., Mokhberi V. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease. Clin Chem Lab Med 2006, 44:1015-1021.
27. Simon A., Chironi G., Gariepy J., Del Pino M., Levenson J. Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men. Atherosclerosis 2005, 179:339-344.
28. Schulze M.B., Shai I., Manson J.E., et al. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes. Diabetologia 2004, 47:2129-2136.
29. Kastelein J.J., van der Steeg W.A., Holme I., et al. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation 2008, 117:3002-3009.
30. Pischon T., Girman C.J., Sacks F.M., Rifai N., Stampfer M.J., Rimm E.B. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005, 112:3375-3383.
31. Chan D.C., Watts G.F. Apolipoproteins as markers and managers of coronary risk. QJM 2006, 99:277-287.
32. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
33. Shinohara K., Shoji T., Tsujimoto Y., et al. Arterial stiffness in predialysis patients with uremia. Kidney Int 2004, 65:936-943.